2. Interdisziplinäre Fallkonferenz - Herz und Hirn – Update 2018

Mittwoch, 14. Februar 2018, 16:15 – 20:00 Uhr, im Lensing Carrée Conference Center Dortmund

Angehörige sind herzlich willkommen: Weitere Intensivstation erhält ...

Die neurologische Intensivstation des Klinikums Dortmund wurde von der "Stiftung Pflege e. V." mit...

Kontakt

Neurologische Ambulanz
Spezialsprechstunde, spezielle Zusatzdiagnostik,
prä und poststationäre Untersuchungen
Telefon: 0231 / 953 - 21815
Sprechstunde:
Mo-Fr 8-16 Uhr

Klinikzentrum Mitte
Beurhausstraße 40
44137 Dortmund

Zentrumsleitung
Prof. Dr. Michael Schwarz
Telefon: 0231 / 953 - 21810

Sekretariat
Frau Pellecchia
Telefon: 0231 / 953 - 21450

Neurologische Klinik Dortmund

Beurhausstraße 40
Karte (für eine größere Ansicht bitte anklicken)

Publikationen Prof. Dr. med. Michael Schwarz

Originalarbeiten

(161) Pergola G, Suchan b, Koch B, Schwarz M, Daum I, Güntürkin O (2012) Quantitative assessment of chronic thalamic stroke.Am J Neuroradiol 10.3174/ajnr.A2897

(160) Peterburs J, Gajda K, Koch B, Schwarz M, Hoffmann KP, Daum I, Bellebaum C (2012) Cerebellar lesions alter performance monitoring on the antisaccade task – An event-related potentials study.Neuropsychologia 50, 379-389

(159) Weiler J, Suchan B, Koch B, Schwarz M, Daum I (2011) Differential impairment of remembering the past and imagining novel events after thalamic lesions.J Cogn Neurosci, im Druck

(158) Peterburs J, Pergola G, Koch B, Schwarz M, Hoffmann KP, Daum I, Bellebaum C (2011) Altered error processing following vascular thalamic damage: evidence from antisaccadic task.PLos One 6, e21517

(157) Willemsen R, Falkenstein M, Schwarz M, Müller T, Beste C (2011) Effects of aging, Parkinson's disease, and dopaminergic medication on reponse selection and control.Neurobiol Aging32, 327-335

(156) Thoma P, Schwarz M, Daum I (2010) Levels-of-processing effects on recollection and familiarity during transient global amnesia and after recovery.Neuropschology 24, 795-803

(155) Peterburs J, Bellebaum C, Koch B, Schwarz M, Daum I (2010) Working memory and verbal fluency deficits following cerebellar lesions: relation to interindividual differences in patient variables.Cerebellum 9, 375-383

(154) Wüllner U, Kassubek J, Odin P, Schwarz M, Naumann M, Häck H-J, Boroojerdi B, Reichmann H, for the NEOPOS Study Group (2010). Transdermal rotigotine for the perioperative management of Parkinson's disease.J Neural Transm 117, 855-859

(153) Willemsen R, Müller T, Schwarz M, Falkenstein M, Beste C (2009) Response monitoring in de novo patients with Parkinsons`s disease.PLos One 4, e4898

(152) PETERS J, THOMA P, KOCH B, SCHWARZ M, DAUM I (2009) Impairment of verbal recollection following ischemic damage of the right anterior hippocampus.Cortex 45, 592-601

(151) SOEI E, KOCH B, SCHWARZ M, DAUM I (2008) Involvement of the mediodorsal thalamus in relational and non-relational memory.Eur J Neurosc 28, 2533-2541

(150) THOMA P, KOCH B, HEYDER K, SCHWARZ M, DAUM I (2008) Subcortical contributions to multitasking and reponse inhibition.Behav Brain Res 194, 214-222

(149) Thoma P, Bellebaum C, Koch B, Schwarz M, Daum I (2008) The cerebellum is involved in reward-based reversal learning.Cerebellum7, 433-443

(148) WILLEMSSEN R, MÜLLER T, SCHWARZ M, HOHNSBEIN J, FALKENSTEIN M (2008) Error processing in patients with Parkinson's disease: the influence of medication state.J Neural Transm 115, 461-468

(147) BELLEBAUM C, KOCH B, SCHWARZ M, DAUM I (2008): Focal basal ganglia lesions are associated with impairments in reward-based reversal learning.Brain 131, 829-841

(146) SCHWARZ M. (2007) Motorische Symptome. Was tun, wenn die medikamentöse Therapie Schuld ist?Info Neurologie & Psychiatrie 9, 41-48

(145) PETERS J, KOCH B, SCHWARZ M, DAUM I (2007) Domain-specific impairment of source memory following a right posterior medial temporal lobe lesion.Hippocampus 17, 505-509

(144) ZAHN R, SCHWARZ M, HUBER W (2006) Functional activation studies of word processing in the recovery from aphasia.J Physiol Paris 99, 370-385

(143) HAUTH EA, DRESCHER R, JANSEN C, GISSLER HM, SCHWARZ M, FORSTING M, JAEGER HJ, MATHIAS KD (2006) Complications and follow-up after unprotected carotid artery stenting.Cardiovasc Intervent Radiol 29, 511-518

(142) Müller T, Fuchs G, Hahne M, Klein W, Schwarz M (2006) Diagnostic aspects of early Parkinson's disease.J Neurol 253 (Suppl 4) 29-31

(141) Bellebaum C, Hoffmann K-P, Koch B, Schwarz m, Daum I (2006) Altered processing of corollary discharge in thalamic lesion patients.Eur J Neurosc 24, 2375-2388

(140) HAUTH EA, JANSEN C, DRESCHER R, SCHWARZ M, CHRISTMANN A, JAEGER H, FORSTING M, MATHIAS K (2006) Angiographische Verlaufskontrolle nach Stentimplantation zur Behandlung der Karotisbifurkationsstenose. Röfo 178, 794-800

(139) JOKISCH D, TROJE NF, KOCH B, SCHWARZ M, DAUM I (2005) Differential involvement of the cerebellum in biological and coherent motion perception.Eur J Neurosc 21, 3439-3446

(138) BELLEBAUM C, DAUM I, KOCH B, SCHWARZ M, HOFFMANN KP (2005) The role of the human thalamus in processing corollary discharge.Brain 128, 1139-1154

(137) SCHWARZ M, BAAS H, EBERSBACH G, JÖRG J, KUHN W, RIEKE J, SCHNITZLER A, SCHWARZ J (2005): Formen und Ausprägungen von Spätkomplikationen.Akt Neurol32, S102-S105

(136) Kabakci K, Isbruch K, Schilling K, Hedrich K, de Carvalho Aguiar P, Ozelius LJ, Kramer PL, Schwarz MHRM, Klein C (2005) Genetic heterogeneity in rapid onset dystonia-parkinsoism: description of a new family.J Neurol Neurosurg Psychiatry 76, 860-862

(135) KOSINSKI CM, MULL M, SCHWARZ M, KOCH B, BINIEK R, SCHLÄFER J, MILKEREIT E, WILLMES K, SCHIEFER J (2004): Do normal D-dimer levels reliably exclude cerebral sinus thrombosis?Stroke 35, 2820-2825

(134) LEWALD J, Schirm S, Schwarz M (2004) Sound lateralization in Parkinson's disease.Cogn Brain Res 21, 335-341

(133) BLOCK F, LOOS M, FROHN C, SCHWARZ M (2004): Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion.Brain Res 998, 29-35

(132) Zahn R, SCHWARZ M, Drews E, Specht K, Kemeny S, Reith W, Willmes K, Huber W (2004): Recovery of semantic word processing in global aphasia: a functional MRI study.Cogn Brain Res 18, 322-336

(131) ZOPPELT D, Koch B, Schwarz M, Daum I (2003): Involvement of the mediodorsal thalamic nucleus in mediating recollection and familiarity.Neuropsychologica 41, 1160-1170

(130) STENZEL W, SCHWARZ M (2003): Sweet's Syndrome associated with acute benign encephalitis - a drug induced aetiology?J Neurol 250, 770-771

(129) Zahn R, Huber W, Drews E, Specht K, Kemeny S, Reith W, Willmes K, Schwarz M (2002): Recovery of semantic word processing in transcortical sensory aphasia: a fMRI study.Neurocase 8, 376-386

(128) FELLOWS S, TABAZA R, HEUMANN M, KLOTZ W, NEUMANN O, SCHWARZ M, NOTH J, TÖPPER R (2002) Modification of a functional motor task by non-consciously perceived sensory stimuli.NeuroReport 13, 637-640

(127) FIMM B, ZAHN R, MULL M, KEMENY S, BUCHWALD F, BLOCK F, SCHWARZ M (2001): Asymmetries of visual attention after circumscribed subcortical vascular lesions.J Neurol Neurosurg Psych 71, 652-657

(126) BLOCK F, SCHMIDT W, NOLDEN-KOCH M, SCHWARZ M (2001): Rolipram reduces excitotoxic neuronal damage.Neuroreport 12, 1507-1510

(125) FELLOWS SJ, ERNST J, SCHWARZ M, TÖPPER R, NOTH J (2001): Precision grip deficits in cerebellar disorders in man.Clin Neurophysiol 112, 1793-1802

(124) REICHMANN H, BECKER A, FUCHS GA, LACHENMEYER L, MÜLLER D, MÜNGERSDORF M, SCHWARZ M (2001): Therapie von Patienten mit idiopathischem Parkinson-Syndrom.Akt Neurol 28, S253-S255

(123) SCHWARZ M, FELLOWS SJ, SCHAFFRATH C, NOTH J (2001): Deficits in sensorimotor control during precise hand movements in Huntington's disease.Clin Neurophysiol112, 95-106

(122) ZAHN R, HUBER W, DREWS E, ERBERICH S, KRINGS T, WILLMES K, SCHWARZ M (2000): Hemispheric lateralization at different levels of human auditory word processing: a functional magnetic resonance imaging study.Neurosc Lett 287, 195-198

(121) KOSINSKI CM, CHA J-H, YOUNG AB, MANGIARINI L, BATES G, SCHIEFER J, SCHWARZ M (1999): Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice.NeuroReport 10, 3891-3896

(120) Gobbele R, Schoen SW, Schröder JM, Vorwerk D, Schwarz M (1999): S-1 radiculopathy as a possible predisposing factor in focal myositis with unilateral hypertrophy of the calf muscles.J Neurol Sci 170, 64-68

(119) SCHWARZ M (1999): Spastik: Pathophysiologie, Klinik und Pharmakotherapie. 3. Pharma-kotherapie.Akt. Neurol 26, 215-224

(118) TÖPPER R, SCHWARZ M, NOTH J (1999) Klinik, Pathophysiologie und klinische Neurophysiologie der Chorea.Klin Neurophysiol 30, 81-89

(117) NOTH J, SCHWARZ M (1999) Muskeltonus: Neurophysiologische Grundlagen und pathologische Abweichungen.Klin Neurophysiol 30, 69-80

(116) KOSINSKI CM, CHA J-H, YOUNG AB, SCHWARZ M (1999): Chorea Huntington: Tiermodelle eröffnen neue Hypothesen zu Pathophysiologie und Therapie.Nervenarzt 70, 878-888

(115) SCHRECKENBERGER M, SABRI O, MULL M, SCHWARZ M, THRON A, BÜLL U (1998) Cerebral functional-morphological match or mismatch in cerebrovascular disease: A comparison of flow-volume SPET, CT findings and Doppler sonography. Nucl Med Comm 19, 23-30

(114) FELLOWS S, NOTH J, SCHWARZ M (1998): Precision grip and Parkinson's disease.Brain 121, 1771-1784

(113) Schwarz M, DE BLESER R, POECK K, WEIS J (1998): Primary progressive aphasia: a 14 year follow-up study with neuropathological findings.Brain 121, 115-126

(112) KÜKER W, ROHDE V, SCHWARZ M (1998): Akutes spinales subdurales Hämatom als seltene Ursache einer progredienten Querschnittslähmung: MRT-Diagnostik.Klin Neurorad 8, 199-202

(111) FELLOWS SJ, SCHWARZ M, NOTH J (1999): Cortical involvement in sensorimotor reflex responses of the hand during natural motor tasks.Neurol Psychiatry Brain Res 6, 177-180

(110) Gobbele R, Dahlke C, Mull M, Schwarz M (1999): Amiodaron-induzierte Optikusneuropathie - eine Kasuistik.Nervenarzt 70,560-565

(109) Berardelli A, Noth J, Thompson PD, Bollen E, Curra A, Deuschl G, van Dijk JG, Töpper R, Schwarz M, Ross RAC (1999) Pathophysiology of chorea and bradykinesia in Huntington`s disease.Mov Disord 14, 398-404

(108) BOROOJERDI B, FOLTYS H, FERBERT A, KOSINSKI CM, NOTH J, SCHWARZ M (1999): Orthostatic tremor: is it only related to orthostasis?J Neurol Neurosurg Psychiatry 66 , 284-288

(107) SCHIEFER J, TÖPPER R, SCHMIDT W, BLOCK F, HEINRICH P, NOTH J, SCHWARZ M (1998): Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid.J Neuroimmun, 89, 168-176

(106) Block F, Schwarz M (1998): Neuroprotektion beim Schlaganfall. Eine kritische Bestandsaufnahme.Nervenarzt 70, 101-110

(105) SCHUSTER G, SCHWARZ M, BLOCK F, PERGANDE G, SCHMIDT WJ (1998): Flupirtine. A review of its neuroprotective and behavioral properties.CNS Drug Rev 4, 149-164

(104) Osborne NN, Cazevieille C, Wood JPM, Nash MS, Pergande G. Block F, Kosinski C, Schwarz M (1998): Flupirtine, a non-opioid centrally acting analgesic, acts as a NMDA antagonist.Gen Pharmacol 30, 268-277

(103) Block F, Schwarz M (1998): The b-wave of the electroretinogram as an index of retinal ischemia.Gen Pharmacol 30, 281-287

(102) Block F, Tondar A, Schmidt W, Schwarz m (1998): Delayed treatment with rolipram reduces neuronal damage following global ischemia in rats.NeuroReport 8, 3829-3832

(101) Schreckenberger m, sabri o, mull m, schwarz m, thron a, büll u (1998): Cerebral functional-morphological match or mismatch in cerebrovascular disease: a comparison of flow-volume SPECT, CT findings and doppler sonography.Nucl Med Commun 19, 23-30

(100) Töpper R, Schwarz M, Lange HW, Hefter H, Noth J (1998): Neurophysiological abnormalities in the Westphal variant of Huntington's disease.Mov Disord 13, 920-928

(99) Boroojerdi B, Ferbert A, Schwarz m, Herath H, Noth J (1998): Botulinum toxin treatment of synkinesia and hyperlacrimation following facial palsy.J Neurol Neurosurg Psychiatry 65, 111-114

(98) Block F, Schwarz M (1998): Global ischemic neuronal damage relates to behavioral deficits: a pharmacological approach.Neuroscience 82, 791-803

(97) BLOCK F, GROMMES C, KOSINSKI C, SCHMIDT W, SCHWARZ M (1997): Retinal ischemia induced by the intraluminal suture method in rats.Neurosci Lett 232, 45-48

(96) FELLOWS SJ, SCHWARZ M, SCHAFFRATH C, DÖMGES F, NOTH J (1997): Disturbances of precision grip in Huntington's disease.Neurosci Lett 226, 103-106

(95) Block F, Pergande G, Schwarz M (1997): Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats.Brain Res 754, 279-284

(94) Block F, Schwarz M (1997): Correlation between ischemic hippocampal neuronal damage and spatial learning deficits due to global ischemia.Biochem Pharmacol Behav 56, 755-761

(93) BLOCK F, SCHWARZ M (1997): Effects of antioxidants on ischemic retinal dysfunction.Exp Eye Res 64, 559-564

(92) Weis J, Kretzschmar HA, Windl O, Podoll K, Schwarz M (1996): Fatal spongiform encephalopathy in a patient who handled animal feed.Lancet 348, 1240

(91) DE BLESER R, WEIS J, SCHWARZ (1996): Primary progressive aphasia.Brain Lang 55, 76-78

(90) Mull M, Schwarz M, Thron A (1996): Lesion patterns and angiomorphological conditions in cerebral hemispheric low-flow infarcts.Stroke 28, 118-123

(89) Block F, Schwarz M (1996): Dextromethorphan reduces functional deficits and neuronal damage after global ischemia in rats.Brain Res 741,153-159

(88) Block F, Schwarz M (1996): Memantine reduces functional and morphological consequences induced by global ischemia in rats.Neurosci Lett 208, 41-44

(87) Töpper R, Schwarz M, Noth J (1996): Somatosensorisch evozierte Potentiale bei Basalganglienerkrankungen.Z EEG-EMG 27, 19-24

(86) Schwarz M, Nolden-Koch, Purr J, Pergande G, Block F (1996): Antiparkinsonian effect of flupirtine in monoamine-depleted rats.J Neural Transm 103, 581-590

(85) Block F, Schmitt W, Schwarz M (1996): Pretreatment but not posttreatment with GYKi 52466 reduces functional deficits and neuronal damage after global ischemia in rats.J Neurol Sci 139, 167-172

(84) Osborne NN, Schwarz M, Pergande G (1996): Protection of rabbit retina from ischemic injury by flupirtine.Investigat Ophthal Vis Sci 37, 274-280

(83) Fellows S, Töpper R, Schwarz M, Thilmann A, Noth J (1996): Stretch reflexes of the proximal arm in a patient with mirror movements: absence of bilateral long-latency components.Electroenc Clin Neurophysiol 101, 79-83

(82) Block F, Schmitt W, Schwarz M (1995): The antioxidant LY 231617 ameliorates functional and morphological sequelae induced by global ischemia in rats.Brain Res 694, 308-311

(81) De Bleser R, Faiss J, Schwarz M (1995): Rapid recovery of aphasia and deep dyslexia after cerebrovascular left-hemisphere damage in childhood.J Neuroling 9, 9-22

(80) Pantel J, De Bleser R, Schwarz M, Weiller C (1995): Rapid progressive form of posterior dysfunction with aperceptive agnosia in a 34 year old man. Neuropsychological analysis and PET follow-up.Neurocase 1, 319-329

(79) Schwarz M, Schmitt T, Pergande G, Block F (1995): N-methyl-D-aspartate and a2adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats.Eur J Pharmacol 276, 247-255

(78) Timmann D, Plummer C, Schwarz M, Diener HC (1995): Influence of flupirtine on human lower limb reflexes.Electroenceph Clin Neurophysiol 97, 184-188

(77) Schick U, May A, Schwarz M (1995): Detection of mycobacterial DNA in a patient with neurosarcoidosis.Acta Neurol Scand 91, 280-282

(76) Osborne NN, Pergande G, Block F, Schwarz M (1994): Immunhistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate (NMDA) and homocysteic acid-induced release of GABA in the rabbit retina.Brain Res 667, 291-294

(75) Block F, Schwarz M (1994): Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesions in rats.NeuroReport 5, 2237-2240

(74) Block F, Pergande G, Schwarz M (1994): Flupirtine protects against ischemic retinal dysfunction in rats.NeuroReport 5, 2630-2632

(73) Töpper R, Gehrmann J, Banati R, Schwarz M, Block F, Noth J, Kreutzberg GW (1994): Rapid appearance of ß-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury.Acta Neuropathol 89, 23-28

(72) Schwarz M, Block F, Pergande G (1994): N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats.NeuroReport 5, 1981-1984

(71) May A, Faiss J, Keidel M, Schwarz M, Weiller C (1994): Zerebrale Angiitis oder zentrale Nebenwirkung nach lumbaler Meylographie (mit intrazerebral nachweisbaren Spasmen)?Nervenarzt 65, 125-127

(70) Block F, Schwarz M (1994): The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.Eur J Pharmacol 256, 149-156

(69) Schwarz M, Block F (1994): Visual and somatosensory evoked potentials are mediated by excitatory amino acid receptors in the thalamus.Electroenceph Clin Neurophysiol 91, 392-398

(68) Timmann D, Belting C, Schwarz M, Diener HC (1994): Influence of visual and somatosensory input on leg EMG responses in dynamic postugraphy in normals.Electroenceph Clin Neurophysiol 93, 7-14

(67) Kastrup O, Gastpar M, Schwarz M (1994): Acute dystonia under clozapine.J Neurol Neurosurg Psychiatry 57, 119

(66) Myers RH, MacDonald ME, Koroshetz W, Duyao MP, Ambrose CM, Taylor SAM, Barnes G, Sirindhi J, Lin CS, Whaley WL, Lazzarini AM, Schwarz M, Wolff G, Bird ED, Vonsattel JP, Gusella JF (1993): De novo expansion of a (CAG)nrepeat in sporadic Huntington's disease.Nature Genet 5, 168-173

(65) Block F, Schwarz M (1993): N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of dextrometorphan in rats.NeuroReport 4, 941-943

(64) Töpper R, Gehrmann J, Schwarz M, Block F, Noth J, Kreutzberg GW (1993): Remote microglial activation in the quinolinic acid model of Huntington's disease.Exp Neurol 123, 271-283

(63) Block F, Schmitt T, Schwarz M (1993): Pentamidine, an inhibitor of rat's spinal flexor reflexes, is a potent N-methyl-D-aspartate (NMDA) antagonist 'in vivo'.Neurosci Lett 155, 208-211

(62) Block F, Schwarz M, Sontag KH (1993): Non-NMDA-mediated transmission of somato-sensory evoked potentials in the rat thalamus.Brain Res Bull 31, 449-454

(61) Schwarz M, Block F (1993): Visual evoked potentials in the rat quinolinic acid model of Huntington's disease.Neurosci Lett 152, 81-83

(60) Block F, Kunkel M, Schwarz M (1993): Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance.Neurosci Lett 149, 126-128

(59) Töpper R, Schwarz M, Podoll K, Dömges F, Noth J (1993): Absence of frontal somatosensory evoked potentials in Huntington's disease.Brain 116, 87-101

(58) Kuwert T, Noth J, Scholz D, Schwarz M, Lange HW, Töpper R, Herzog H, Aulich A, Feinendegen LE (1993): Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.Mov Disord 8, 98-106

(57) Block F, Schwarz M, Sontag KH (1992): Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography.Neurosci Lett 144, 124-126

(56) Schwarz M, Block F, Sontag KH (1992): N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of memantine in rats.Neurosci Lett 143, 105-109

(55) Schwarz M, Block F, Töpper R, Sontag KH, Noth J (1992): Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input.Ann Neurol 32, 358-364

(54) Schwarz M (1992): Pharmakotherapie der Spastik.Neurologie TW Psychiatrie 6, 141-146

(53) Thilmann AF, Schwarz M, Töpper R, Fellows SJ, Noth J (1991): Different mechanisms underlie the M2 stretch reflex response of active human muscle at different joints.J Physiol (Lond) 444, 631-643

(52) Noth J, Schwarz M, Podoll K, Motamedi F (1991): Evidence that low-threshold muscle afferents evoke long-latency stretch reflexes in human hand muscles.J Neurophysiol 65, 1089-1097

(51) Podoll K, Schwarz M. Noth J (1991): Language functions in progressive supranuclear palsy.Brain 114, 1457-1472

(50) Turski L, Diedrichs S, Klockgether T, Schwarz M, Turski WA, Sontag KH, Bortolotto ZA, Calderazzofilho LS, Cavalheiro EA (1991): Paradoxical anticonvulsant activity of the g-aminobutyrate antagonist bicuculline methiodide in the rat striatum.Synapse 7, 14-20

(49) Turski L, Klockgether T, Schwarz M, Turski WA, Sontag KH (1990): Substantia nigra: a site of action of muscle relaxant drugs.Ann Neurol 28, 341-348

(48) Podoll K, Schwarz M, Noth J (1990): Charles Bonnet Syndrom bei einem Parkinson Patienten mit beidseitigem Visusverlust.Nervenarzt 61, 52-56

(47) Turski L, Klockgether T, Turski WA, Schwarz M, Sontag KH (1990): Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases.Brain Res 512, 125-131

(46) Klockgether T, Schwarz M, Wüllner U, Turski L, Sontag KH (1989): Myorelaxant effect after intrathecal injection of antispastic drugs in rats.Neurosci Lett 97, 221-226

(45) Noth J, Schürmann M, Podoll K, Schwarz M (1988): Reconsideration of the concept of enhanced static fusimotor drive in rigidity in patients with Parkinson's disease.Neurosci Lett 84, 239-243

(44) Klockgether T, Schwarz M, Turski L, Sontag KH (1988): Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.Exp Brain Res 70, 445-47

(43) Podoll K, Schwarz M, Noth J (1988): Sprachverhalten bei Patienten mit progressiver supranukleärer Blicklähmung.Psycho 14, 388-390

(42) Schwarz M, Klockgether T, Wüllner U, Turski L, Sontag KH (1988): d-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system.Exp Brain Res 70, 618-626

(41) Klockgether T, Turski L, Schwarz M, Sontag KH, Lehmann J (1988): Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine.Brain Res 461, 343-348

(40) Löscher W, Czuczwar SJ, Jäckel R, Schwarz M (1987): Effect of microinjections of g-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats.Exp Neurol 95, 622-638

(39) Turski L, Klockgether T, Turski W, Schwarz M, Sontag KH (1987): Substantia nigra and motor control in the rat: effect of intranigral a-kainate and g-D-glutamylaminomethylsulphonate on motility.Brain Res 424, 37-48

(38) Turski L, Klockgether T, Schwarz M, Sontag KH, Meldrum BS (1987): Unusual interactions of excitatory amino acid receptor agonists: a- and b-kainate antagonize motor responses to N-methyl-D-aspartate in rodents.Neuroscience 20, 285-292

(37) Meldrum BS, Turski L, Schwarz M, Czuczwar SJ, Sontag KH (1986): Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio.Naunyn Schmiedeberg's Arch Pharmacol 332, 93-97

(36) Ellenbroek B, Klockgether T, Turski L, Schwarz M (1986): Distinct sites of functional interaction between dopamine, acetylcholine and g-aminobutyrate within the neostriatum: an electromyographic study in rats.Neuroscience 17, 79-88

(35) Turski L, Cavalheiro EA, Schwarz M, Turski WA, Mello DM, Bortolotto ZA, Klockgether T, Sontag KH (1986): Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or g-vinyl-GABA into the substantia nigra.Brain Res 370, 294-309

(34) Schwarz M, Ikonomidou C, Klockgether T, Turski L, Ellenbroek B, Sontag KH (1986): The role of striatal cholinergic mechanisms for the development of limb rigidity: an electromyographic study in rats.Brain Res 373, 365-372

(33) Turski L, Schwarz M, Klockgether T, Sontag KH (1986): Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine.Brain Res 379, 367-371

(32) Ikonomidou-Turski C, Schwarz M, Turski L, Sontag KH (1986): Muscle relaxant action of phenobarbitone in genetically spastic rats: an electromyographic study.Eur J Pharmacol 128, 1-7

(31) Heim C, Schwarz M, Klockgether T, Jaspers R, Cools AR, Sontag KH (1986): GABAergic neurotransmission within the reticular part of the substantia nigra (SNR): role for switching motor patterns and performance of movements.Exp Brain Res 63, 375-381

(30) Klockgether T, Schwarz M, Turski L, Sontag KH (1986): The rat ventromedial thalamic nucleus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission.J Neurosci 6, 1702-1711

(29) Klockgether T, Turski L, Schwarz M, Sontag KH (1985): Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleus.Brain Res 399, 1-9

(28) Wand P, Schwarz M (1985): Two types of cat static fusimotor neurones under separate central control?Neurosci Lett 58, 145-149

(27) Ellenbroek B, Schwarz M, Sontag KH, Jaspers R, Cools AR (1985): Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats.Brain Res 345, 132-140

(26) Schwarz M, Löscher W, Turski L, Sontag KH (1985): Disturbed GABAergic transmission in mutant Han-Wistar rats: further evidence for basal ganglia dysfunction.Brain Res 347, 258-267

(25) Klockgether T, Schwarz M, Turski L, Sontag KH (1985): ZK 91296, an anticonvulsant b-carboline which lacks muscle relaxant properties.Eur J Pharmacol 110, 309-315

(24) Ikonomidou C, Turski L, Klockgether T, Schwarz M, Sontag KH (1985): Effects of methyl b-carboline-3-carboxylate, Ro 15-1788 and CGS 8216 on muscle tone in genetically spastic rats.Eur J Pharmacol 113, 205-213

(23) Klockgether T, Pardowitz I, Schwarz M, Sontag KH, Turski L (1985): Evaluation of the muscle relaxant properties of a novel b-carboline, ZK 93423, in rats and cats.Br J Pharmacol 86, 357-366

(22) Turski L, Schwarz M, Turski WA, Sontag KH (1985): Muscle relaxant action of 2-chloroadenosine in genetically spastic rats is independent of g-aminobutyric acid-mediated inhibition.Neurosci Lett 54, 369-374

(21) Ellenbroek B, Schwarz M, Sontag KH, Cools AR (1985): The importance of the striato-nigro-collicular pathway in the expression of haloperidol-induced tonic electromyographic activity.Neurosci Lett 54, 189-194

(20) Klockgether T, Schwarz M, Turski L, Wolfarth S, Sontag KH (1985): Rigidity and catalepsy after injections of muscimol into the ventromedial thalamic nucleus: an electromyographic study in the rat.Exp Brain Res 58, 559-569

(19) Turski L, Schwarz M, Turski WA, Klockgether T, Sontag KH, Collins JF (1985): Muscle relaxant action of excitatory amino acid antagonists.Neurosci Lett 53, 321-326

(18) Schwarz M, Sontag KH, Wand P (1984): Non-dopaminergic neurones of the reticular part of substantia nigra can gate static fusimotor action onto flexors in cat.J Physiol (Lond) 354, 333-344

(17) Schwarz M, Sontag KH, Wand P (1984): Sensory-motor processing in substantia nigra pars reticulata in conscious cats.J Physiol (Lond) 347, 129-147

(16) Turski WA, Cavalheiro EA, Bortolotto ZA, Mello LM, Schwarz M, Turski L (1984): Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis.Brain Res 321, 237-253

(15) Ellenbroek B, Schwarz M, Sontag KH, Cools A (1984): The role of the colliculus superior in the expression of muscular rigidity.Eur J Pharmacol 104, 117-123

(14) Jaspers R, Schwarz M, Sontag KH, Cools AR (1984): Caudate nucleus and programming behaviour in cats: role of dopamine in switching motor patterns.BehavBrain Res 14, 17-28

(13) Schwarz M, Turski L, Sontag KH (1984): CGS 8216, Ro 15-1788 and methyl-b-carboline-3-carboxylate, but not EMD 41717 antagonize the muscle relaxant effect of diazepam in genetically spastic rats.Life Sci 35, 1445-1451

(12) Turski L, Schwarz M, Sontag KH (1984): Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: A genuine model of basal ganglia dysfunction?Behav Brain Res 12, 29-37.

(11) Turski L, Schwarz M, Turski WA, Ikonomidou C, Sontag K-H (1984): Effect of aminophylline on muscle relaxant action of diazepam and phenobarbitone in genetically spastic rats: Further evidence for a purinergic mechanism in the action of diazepam.Eur J Pharmacol 103, 99-105.

(10) Czuczwar SJ, Turski L, Schwarz M, Turski WA, Kleinrok Z (1984): Effects of excitatory amino acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice.Eur J Pharmacol 100, 357-362.

(9) Turski L, Schwarz M, Sontag K-H (1984): A specific benzodiazepine antagonist CGS 8216 reverses the muscle relaxant effect of diazepam but not of phenobarbitone.Eur J Pharmacol 98, 441-444.

(8) Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L (1983): Limbic seizures produced by pilocarpine in rats: behavioural, electroen-cephalographic and neuropathological study.Behav Brain Res 9, 315-336.

(7) Schwarz M, Turski L, Sontag KH (1983): Reversal of the muscle relaxant effect of diazepam but not of progabide by a specific benzodiazepine antagonist: Ro 15-1788.Eur J Pharmacol 90, 139-142.

(6) Havemann U, Turski L, Schwarz M, Kuschinsky K (1983): Nigral GABAergic mechanisms and EMG activity in rats: Differences between pars reticulata and pars compacta.Eur J Pharmacol 92, 49-56.

(5) Schwarz M, Turski L, Janiszewski W, Sontag KH (1983): Is the muscle relaxant effect of diazepam in spastic mutant rats mediated through GABA-independent benzodiazepine receptors?Neurosci Lett 36, 175-180.

(4) Turski L, Havemann U, Schwarz M, Kuschinsky K (1982): Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation.Life Sci 31, 2327-2330.

(3) Turski L, Schwarz M, Sontag KH (1982): Interaction between phenytoin and diazepam in mutant Han-Wistar rats with progressive spastic paresis.Naunyn-Schmiedeberg's Arch Pharmacol 32, 48-51.

(2) Sontag KH, Wand P, Schwarz M, Wesemann W, Osborne NN (1982): Die Wirkung von Memantin auf Gehalt von Dopamin, Noradrenalin und Serotonin des Striatums und lumbalen Rückenmarks der Ratte und der Katze.Arzneim-Forsch/Drug Res 32, 1236-1240.

(1) Wand P, Schwarz M, Kolasiewicz W, Sontag KH (1981): Nigral output neurons are engaged in regulation of static fusimotor action onto flexors in cat.Pflügers Arch 391, 255-257.

Buchbeiträge:
(37) SCHWARZ M (2008) Spastik. In Block F (Hrsg.), Kompendium der neurologischen Pharmakotherapie. Springer, Heidelberg, S. 1-24

(36) SCHWARZ M (2008) Bewegungsstörungen. In Block F (Hrsg.), Kompendium der neurologischen Pharmakotherapie. Springer, Heidelberg, S. 25-122

(35) SCHWARZ M (2006) Dystonien. In Block F, Prüter C (Hrsg.) Medikamentös induzierte neurologische und psychiatrische Störungen, Springer, Heidelberg, S. 217-230

(34) SCHWARZ M (2006) Prionerkrankungen. In: Berlit P (Hrsg.), Klinische Neurologie, 2. Auflage, Springer, Heidelberg, S. 705-707 2006

(33) SCHWARZ M (2006) Chorea. In: Berlit P (Hrsg.), Klinische Neurologie, 2. Auflage, Springer, Heidelberg, S. 904-909

(32) SCHWARZ M (2006) Morbus Wilson. In: Berlit P (Hrsg.), Klinische Neurologie, 2. Auflage, Springer, Heidelberg, S. 909-912

(31) SCHWARZ (2004) Myotonolytika. In: Fox JM, Jörg J (Hrsg.), Neurologische Pharmakotherapie. Thieme, Stuttgart-New York, S. 162-190

(30) SCHWARZ M (1998) Motorische Störungen aus neurologischer Sicht: Dystonien. In: Gaebel, Falkai (Hrsg.), Zwischen Spezialisierung und Integration. Perspektiven der Psychiatrie und Psychotherapie. Springer, Wien, New York, 228-231.

(29) SCHWARZ M, NOTH J (1999) Chorea und Ballismus. In: Hopf HC, Deuschl G, Diener HC, Reichmann H (Hrsg.), Neurologie in Praxis und Klinik, Thieme, Stuttgart, 78-86

(28) NOTH J, SCHWARZ M (1999) Tics. In: Hopf HC, Deuschl G, Diener HC, Reichmann H (Hrsg.), Neurologie in Praxis und Klinik, Thieme, Stuttgart, 86-90

(27) SCHWARZ M (1999) Morbus Wilson. In: Berlit P (Hrsg.), Klinische Neurologie, Springer, Berlin, Heidelberg, New York, S. 923-926

(26) SCHWARZ M (1999) Creutzfeldt-Jakob-Krankheit. In: Berlit P (Hrsg.), Klinische Neurologie, Springer, Berlin, Heidelberg, New York, S. 713-716

(25) SCHWARZ M (1999) Multisystematrophie. In: Berlit P (Hrsg.), Klinische Neurologie, Springer, Berlin, Heidelberg, New York, S. 917-923

(24) SCHWARZ M (1999) Chorea. In: Berlit P (Hrsg.), Klinische Neurologie, Springer, Berlin, Heidelberg, New York, S. 883-886

(23) SCHRECKENBERGER M, SABRI O, MULL M, SCHWARZ M, THRON A, BÜLL U (1997) Regional cerebral perfusion and its reserve compared to CT findings in 100 patients with cerebrovascular disease. In: Klingelhöfer J, Bartels E, Ringelstein EB (Hrsg.), New Trends in Cerebral Hemodynamics an Neurosonology. Elsevier Science, Amsterdam, 156-161

(22) SCHWARZ M (1996) Klinisch-Neurologische Diagnostik. In: Schumpelick V, Töns C (Hrsg.), Chirurgische Notfall- und Intensivmedizin, Enke-Verlag, S. 266-272

(21) Schwarz M, Wenz S, Quadflieg G, Block F (1994): Protektive Wirkung von Glutamatantagonisten und Radikalfängern im Chinolinsäuremodell der Chorea Huntington. In: Jerusalem F, Ries F (Hrsg.), Verhandlungen der Deutschen Gesellschaft für Neurologie 8, S. 560-561

(20) Töpper R, Gehrmann J, Schwarz M, Block F, Noth J, Kreutzberg GW (1994): Transsynaptic microglial reactions in the quinolinic acid model of Huntington's disease. In: Percheron G, McKenzie JS, Feger J (Eds.), The Basal Ganglia IV, Plenum Press, New York, pp. 179-183

(19) Schwarz M, Töpper R, Podoll K, Noth J (1994): Klinische und elektrophysiologische Diagnose der Chorea Huntington. In: Huffmann G , Braune HJ (Hrsg.), Extrapyramidal-motorische Erkrankungen, Eichhorn Presse Verlag, Reinbek, S. 506-513

(18) Schwarz M, Block F (1993): Muscle relaxant action of excitatory amino acid antagonists in rats. In: Thilmann AF, Burke D, Rymer WZ (Eds.), Spasticity: Mechamisms and Management, Springer, Berlin, Heidelberg, New York, pp. 387-397

(17) Noth J, Schwarz M (1992): Differences in reflex control of distal and proximal arm muscles as revealed in patients with central motor disorders. In: Jami L, Pierrot-Deseilligny E, Zytnicki D (Eds.), Muscle afferents and spinal control of movement, Pergamon Press, Oxford, pp. 421-426

(16) Choi DW, Barde YA, Chalfie M, Heinemann U, Horvitz HR, Kosik KS, Müller HW, Schwarcz, R, Schwarz M, Shooter EM, Siesjö BK, Unsicker K (1991): Neuronal death and survival. In: Price DL, Thoenen H, Aguayo AJ (Eds.), Neurodegenerative Disorders, Mechanisms and Prospects for Therapy, Dahlem Konferenzen, John Wiley & Sons, Chichester, pp. 230-250

(15) Windhorst U, Burke RE, Dieringer N, Evinger C, Feldman AG, Hasan Z, Hultborn H, Illert M, Lundberg AP, Macpherson JM, Massion J, Nichols TR, Schwarz M, Vilis T (1991): What are the output units of motor behaviour and how are they controlled? In: Humphrey DR, Freund HJ (Eds.), Motor Control: Concepts and Issues, Dahlem Konferenzen, John Wiley & Sons, Chichester, pp. 357-381

(14) Schwarz M, Schulte-Tamburen A, Noth J (1990): Static fusimotor activity in Parkinsonian rigidity: reconsideration of an old concept. In: Berardelli A, Benecke R, Manfredi M, Marsden CD (Eds.), Motor Disturbances II, Academic Press, London, pp. 191-201

(13) Turski WA, Klockgether T, Ikonomidou C, Turski L, Schwarz M, Sontag KH (1988): Basal ganglia and motor control in the rat: effect of intrastriatal and intrapallidal 2-amino-7-phosphonoheptanoate on motility. In: Cavalheiro EA, Lehmann J, Turski L (Eds.), Frontiers in Excitatory Amino Acid Research, Alan R. Liss, New York, pp. 497-500

(12) Klockgether T, Turski L, Schwarz M, Sontag KH (1988): Functional role of excitatory amino acid receptors in the rat thalamus. In: Cavalheiro EA, Lehmann J, Turski L (Eds.), Frontiers in Excitatory Amino Acid Research, Alan R. Liss, New York, pp. 481-488

(11) Turski L, Klockgether WA, Turski C, Ikonomidou C, Schwarz M, Sontag KH (1988): Muscle relaxant action of excitatory amino acid antagonists: sites of action. In: Cavalheiro EA, Lehmann J, Turski L (Eds.), Frontiers in Excitatory Amino Acid Research, Alan R. Liss, New York, pp. 343-350

(10) Schwarz M, Klockgether T, Turski L, Sontag KH (1988): Intrathecal injection of antispastic drugs in rats: muscle relaxant action of midazolam, baclofen, 2-aminophosphono-heptanoic acid (AP7) and tizanidine. In: Müller H, Zierski J, Penn RD (Eds.), Local Spinal Therapy of Spasticity, Springer, Berlin, Heidelberg, New York, pp. 65-79

(9) Klockgether T, Schwarz M, Turski L, Ikonomidou-Turski C, Ossowska K, Heim C, Turski L, Wüllner U, Sontag KH (1987): Neurotransmitters in the basal ganglia: their role for the regulation of muscle tone. In: Carpenter MB, Jayaramann A (Eds.), The Basal Ganglia II: Structure and Function - Current Concepts, Plenum Press, New York, London, pp. 185-202

(8) Klockgether T, Turski L, Schwarz M, Sontag KH (1987): Behavioural effects of excitatory amino acid antagonists within the rat ventromedial thalamic nucleus. In: Hicks TP, Lodge D, McLennan H (Eds.), Excitatory Amino Acid Transmission, Alan R. Liss, New York, pp. 365-368

 (7) Turski L, Klockgether L, Schwarz M, Sontag KH, Meldrum BS (1987): a- and b-kainate antagonise seizures produced by N-methyl-D-aspartate in mice. In: Hicks TP, Lodge D, McLennan H (Eds.), Excitatory Amino Acid Transmission, Alan R. Liss, New York, pp. 257-260

(6) Turski L, Klockgether L, Schwarz M, Turski WA, Sontag KH (1986): Spinal cord: a site of muscle relaxant action of excitatory amino acid antagonists. In: Roberts PJ, Storm-Mathisen J, Bradford HF (Eds.) Excitatory Amino Acids, MacMillan, London, pp. 459-461

(5) Turski L, Schwarz M, Cavalheiro EA, Turski WA, Ikonomidou C, Sontag KH (1985): Nigral GABAergic mechanisms modify the development of seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuroanatomical evidence. J Cereb Blood Flow Metab 5, Suppl 1, S 363-364

(4) Turski L, Schwarz M, Golembiowska-Nikitin K, Osborne NN, Sontag KH (1985): Intrastriatal bethanechol in rats: seizures and brain damage. J Cereb Blood Flow Metab 5, Suppl 1, S 361-362

(3) Cools AR, Jaspers R, Schwarz M, Sontag KH, Vrijmoed-de Vries M, Van den Bercken J (1984): Basal ganglia and switching motor programs. In: McKenzie JS, Kemm RE, Wilcock LN (Eds.), The Basal Ganglia I, Structure and Function, Plenum Press, New York, pp. 513-544

(2) Sontag KH, Heim C, Schwarz M, Jaspers R, Cools AR, Wand P (1984): Consequences of disturbed GABAergic transmission in substantia nigra pars reticulata in freely moving cats on their motor behaviour, and in anaesthetized cats on their spinal motor elements. In: McKenzie JS, Kemm RE, Wilcock LN (Eds.), The Basal Ganglia I, Structure and Function, Plenum Press, New York, pp. 495-511

(1) Turski WA, Czuczwar SJ, Kleinrok Z, Schwarz M, Turski L (1983): Intraamygdaloid morphine produces seizures and brain damage in rats. Life Sci 33, Suppl 1, 615-618